A 17-year-old girl presented with acute-onset cervical pain, followed by left arm weakness and gait disturbances. Spinal cord astrocytoma was diagnosed by MRI performed at an outpatient facility (figure, A and B). The patient was admitted to the neurosurgery department to undergo spinal cord biopsy. A second neurologic evaluation indicated neuromyelitis optica (NMO) as the most likely diagnosis, which was confirmed by NMO-immunoglobulin G seropositivity. The patient was treated with rescue plasmapheresis with substantial clinical and radiologic (figure, C) improvement.
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NMO presenting with longitudinally extensive spinal cord lesions resulting in a "swollen cord" appearance and involving a whole cross-sectional area of the cord may be initially misdiagnosed as spinal cord intramedullary tumor.
1,2 Spinal cord tumors should be added to the differential diagnosis of NMO including transverse myelitis, spinal cord ischemia, and systemic autoimmune disease.
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